Medical

BEA-17 Granted Orphan Drug Designation By FDA For The Treatment Of Glioblastoma

Data from a study recently published by the Royal Marsden Cancer Centre showed promising data for the combination of Avutometinib + Defactinib in the treatment of ovarian cancer, resulting in significant tumour shrinkage in 28% of patients and disease control in 93% of patients.

Healthy

How To Treat Kidney Deficiency And Poor Spleen And Stomach

Most patients with kidney deficiency feel that their spleen and stomach are not very good, at this time they should not eat spicy and stimulating food, but also eat less and more often, and should not overeat.

Disease

What Will Happen If You Don't Treat Your Piles?

When it comes to hemorrhoids, many people probably think of the fierce, unspeakable, restless pain

Apparatus

New Study Reveals Antibiotic Abuse For Sore Throats Pushes Up The Third Leading Cause Of Death Worldwide

Misconceptions about how to treat a sore throat are fuelling the overuse of antibiotics, according to STAR research.

Apparatus

Stavudol Paediatric Indication Approved For The Treatment Of Children Aged 3 Months And Older With Complicated Intra-Abdominal Infections

There is an urgent clinical need for new antimicrobial drugs to break through the dilemma of cIAI treatment in children and address the growing challenge of drug resistance.

Medical

Study Shows That a Blood Pressure Drug Combined With Radiotherapy Improves Outcomes In Locally Advanced Pancreatic Cancer

Pancreatic cancer is known to be a highly fatal and incurable type of cancer known as the "king of cancers". Currently, the only possible cure for pancreatic cancer is the complete surgical removal of the tumour tissue. Once the cancer has spread beyond the pancreatic organ, the patient's treatment options are very limited.

Medical

Chemotherapy May Promote Resistance To Immunotherapy In Pancreatic Cancer, Study Shows

Immunotherapy has been a very important treatment in recent years, with many patients in lung cancer, malignant melanoma and many other cancers experiencing dramatic improvements in prognosis with this cutting-edge therapy. In pancreatic cancer, however, progress in immunotherapy has been very slow and its effectiveness has been extremely limited.

Apparatus

Biyze For The Treatment Of Chronic Lymphocytic Leukaemia And Marginal Zone Lymphoma

Prior to the granting of marketing authorisation by the MHRA, Biyze® had been approved by the European Commission for a number of indications and is currently the only drug approved for the treatment of MZL in Great Britain.